LeafNLP Demos
Back to explore

Report #2888366

Received Mar 10, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
76 yrs
State
NC
Recovered
Unknown
Vaccinated
Dec 15, 2025
Onset
Dec 15, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALS195B34IM

Symptoms (1)

Expired product administered

Symptom narrative

produst administered to patient after expiration date; This non-serious case was reported by a nurse and described the occurrence of expired vaccine used in a 76-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 95B34, expiry date 18-NOV-2025) for prophylaxis. On 15-DEC-2025, the patient received the 1st dose of Arexvy (intramuscular) .5 ml. On 15-DEC-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: produst administered to patient after expiration date). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 03-MAR-2026 This case is linked with US2026AMR019283, reported by same reporter.; Sender's Comments: US-GSK-US2026AMR019283:same reporter